Evaluating Service Delivery and Patient Safety Interventions

Slides:



Advertisements
Similar presentations
Workshop C – Evaluation Rod Taylor Complex Interventions Research Framework Masterclass 2010.
Advertisements

Health Economics and ONS
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
Continuity of Medication Management Medication Reconciliation: Beyond Admission Hospital Presenter Month YYYY.
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-
Trigger Tools 4 th February 2009 Presenter: Liz Baines.
Happy semester with best wishes from all nursing staff Dr Naiema Gaber
Research Methodology for Rare Diseases Rare Disease Group 14:00 3 rd October 2012 Richard Lilford.
How to Design a Quality Improvement Project
1 Lecture 20: Non-experimental studies of interventions Describe the levels of evaluation (structure, process, outcome) and give examples of measures of.
Framing and Measuring Patient Safety Dr Jeanette Jackson This SPSRN work is funded by.
The use of Stepped Wedge cluster randomized trials: Systematic Review Dr Celia Taylor The University of Birmingham On behalf of my co-authors: Noreen Mdege,
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Will This Admission Help? Leonard Hock, D.O., CMD Covenant Hospice.
Copyright © 2006 Elsevier, Inc. All rights reserved Chapter 22 Quality Patient Care.
Theme 2: Hospital design to reduce adverse events CEO, Jane Kraglund Odense University Hospital.
Managing Hospital Safety: Common Safety Concerns Part 1 of 4.
 Promote health, prevent illness/injury  Broad knowledge base needed to meet patient needs in different health care settings.
Supervision by the Dutch Health Care Inspectorate: what are the effects on health? Sandra Oude Wesselink Erasmus Medical Center, department of Public Health.
Together we can do so much February 5th , 2016:
Presentation Developed for the Academy of Managed Care Pharmacy
PRAGMATIC Study Designs: Elderly Cancer Trials
Study Design: Making research pretty Adam P. Sima, PhD July 13, 2016
Trials Adrian Boyle.
Clinical Pharmacists' Recommendations in Critical Care Areas of an Egyptian Tertiary Care Hospital: Interventions Analysis and Effect on Direct Drug Cost.
The ALERT Trial.
Critical Care Services Pharmacist Royal Manchester Children’s Hospital
NAP6 Perioperative Anaphylaxis
LEADER trial: Primary Outcome
Medication Management With Older Adults
Clinical Studies Continuum
Intervention Development in Elderly Adults (IDEA)
Journal Club Notes.
Epidemiological Studies
The Role of Statistics in Clinical Trials
Interventional trials
Population and samples
Purpose of Critical Appraisal
The Impact of a Structured Balance Training Program on Elderly Adults
Nat. Rev. Nephrol. doi: /nrneph
Stephen W. Waldo et al. JACC 2008;51:
HLT 540 Competitive Success-- snaptutorial.com
HLT 540 Education for Service-- snaptutorial.com
HLT 540 Teaching Effectively-- snaptutorial.com
Crucial Statistical Caveats for Percutaneous Valve Trials
Meta-Analysis: Synthesizing evidence
Pragmatic Trial Designs
11/20/2018 Study Types.
Meta-analysis of randomised phase III clinical trials comparing EGFR tyrosine kinase inhibitor (TKI) shows that male patients with non-small cell lung.
Key Question WHY USE A NON-TRADITIONAL RCT DESIGN?
Team training in emergency obstetrics
By the completion of this presentation, the participant will be able to:
What is Patient Blood Management?
Meta-analysis of randomised phase III clinical trials with ALK inhibitors in non-small cell lung cancer (NSCLC) showing similar benefit in male patients.
Quantitative Research Design
PREDICTORS OF OUTCOME AMONG PATIENTS WITH TRAUMATIC BRAIN INJURY AT MOI TEACHING AND REFERRAL HOSPITAL: ELDORET, KENYA   Judy C. Rotich.
Causal inference for health system effectiveness: hard but essential
Section 1 manuscript edit
Maryland HCW Influenza Vaccination Survey Highlights
Hepatitis C infection among injecting drug users in general practice: a cluster randomised controlled trial of clinical guidelines' implementation by Walter.
Evaluating the Science of Cardiogenic Shock
Nursing Sensitive Indicator: RN Hours Per Patient Day (NHPPD)
The Audio-COT (Clinically Observed Tool) – a friend or foe
Ethics in cluster randomized trials
B-FREE Trial B-FREE Trial Summary.
Journal Editor Perspectives
Surgical safety checklist trial
Cluster Crossovers with Multiple periods
Regulation of Private healthcare facilities in hong kong
Presentation transcript:

Evaluating Service Delivery and Patient Safety Interventions Richard Lilford. Boston 2007 PlenaryLilford--8.22@10.45am QC

Two Key Evaluation Issues Study design End points

Before and After Data-collection Control Intervention Post-intervention Pre-intervention Example: Blood stream infections in ICU. Pronovost et al, 2006

Controlled Cross-Sectional Data-collection Control Intervention Post-intervention Pre-intervention Impact of dedicated medication nurses. Greengold et al 2003

The Concept of Terminal Event

Controlled Before and After Data-collection Control Intervention Post-intervention Pre-intervention Example: Nationally mediated drug reviews: nursing homes v assisted living. Briesacher et al,2005.

Advantage Controlled Before and After 1) Reduce variance (improve precision) 2) Reduce bias (especially non-randomised studies)

Two Key Evaluation Issues Study design End points

Management Processes (Fidelity) Clinical Processes /errors Outcomes and throughput Structure Intervening variables

Management Processes (Fidelity) Clinical Processes /errors Outcomes and throughput Structure Intervening variables Specific interventions

Management Processes (Fidelity) Clinical Processes /errors Outcomes and throughput Structure Intervening variables Generic Interventions Specific interventions

Corollaries for Service Interventions 1) Multiple end-points 2) a) Controlled before and after b) Compare change in outcomes from base-line to post-intervention

CASE STUDY: MERIT TRIAL Control Met p Value 1) Multiple end-points Calls: non-arrest 48.1 84.1 <0.001 2) Change from base-line -0.98 -0.44 0.2 -0.68 -0.31 0.2 Cardiac arrest Unexpected death

Control + MET hospitals combined Base-line Post P Cardiac arrest 2.08 1.47 0.003 1.63 1.11 0.01 Unexpected death

Combined Pre-Post Effect Possible Reasons for Combined Pre-Post Effect 1) General Secular Trend 2) Study effect a) Mediated directly b) Indirect effect

A Design for all Seasons Control Intervention Time

Advantages of Step Wedge Design Ethical, political and logistic 2) Scientific

A Design for all Seasons Control Intervention Time

Scientific Arguments for Step Wedge Cluster Designs Parallel Step-Wedge Intervention effect Sub-groups + + + + + + + + Time-effects General Sustainability (loss of power) Time of intervention/Hawthorne - +

Design 1: Uncontrolled Data-collection Control Intervention Post-intervention